Expanded partnerships with leading European centres create a strategic pathway to accelerate market adoption and drive future commercialisation opportunities...
This acquisition expands Zimmer Biomet's extensive suite of orthopaedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively...
Mytos, a London-based biotech startup, is tackling this bottleneck head-on with its fully automated, closed manufacturing platform...
The first facility, located within the Cell and Gene Therapy Catapult’s (CGT Catapult) Stevenage Manufacturing Innovation Centre, aims to achieve clinical readiness by September 2026...
Ireland’s Ageing Population Will Double Homecare Needs - Data Highlights Planning Required...
The company is preparing for commercial rollout in Europe, where France has emerged as the single largest opportunity, given its high contraceptive usage yet limited permanent alternatives...
H2 Global Group, together with its subsidiary H2 Medical Technologies, has entered a decisive growth stage following strong recognition at LSI Europe 2025 in London...
Philips’ new Rembra RT and Areta RT systems are designed to make cancer treatment planning faster and more accurate...
Femasys leverages Kebomed’s pan-European distribution strength to drive the adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access...
RefluxStop is very well positioned to fill the upcoming treatment gap as our main device competitor exits the European market...
